Precision Nanomedicine for Improved Diagnosis and Treatment

SpagoPix – Bringing Precision to Cancer Imaging

Tumorad® – Expanding Effective Radionuclide Therapy

A Nanomedical Platform to Save Lives and Reduce Healthcare Cost

Investor Relations

Improving Healthcare for Major Disease Areas

Portfolio

Clinical Imaging and Cancer Therapy

About Us

Unique Expertise in Functional Nanomedicine

An Emerging Nanomedicine Leader

We are a Swedish nanomedicine company in clinical development phase with a proprietary platform of polymeric materials that targets more precise diagnosis and treatment of solid tumors.

Our development projects, SpagoPix and Tumorad® have unique properties with potential to significantly improve healthcare for the benefit of cancer patients. Our diagnostic MRI contrast agents candidate SN132D, is currently in clinical testing in breast cancer patients.

Presentations

Erik Penser imaging event

25 May, 2021